NOBIVAC CANINE 1-DAPPVL2+CV – 8 WAY VACCINE

NOBIVAC® CANINE 1-DAPPVL2+CV 

8 WAY VACCINE       25 x 1 mL dose

 

Description

Recommended for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, canine adenovirus type 1 (hepatitis), canine adenovirus type 2 (respiratory disease), canine coronavirus, canine parainfluenza virus, and canine parvovirus and against leptospiral disease due to L. canicola or L. icterohaemorrhagiae.

8 WAY SHOT – Canine Distemper, Adenovirus Type 2, Coronavirus, Parainfluenza, Parvovirus Vaccine, MODIFIED LIVE AND KILLED VIRUS, and Leptospira Canicola-Icterohaemorrhagiae Bacterin

Proven 1-year vaccine that offers broad protection for dogs against distemper, adenovirus types 1 and 2, parvovirus, parainfluenza, coronavirus, and leptospirosis due to L. canicola or L. icterohaemorrhagiae.

Features and Benefits
  • Protects against all known strains of canine parvovirus (CPV), including CPV-2c1,2
    • Contains CPV-2b, one of the most prevalent field strains of parvovirus
    • High antigenic mass (titer), low passage parvovirus vaccine
    • Overrides maternal antibodies in young puppies.3
  • Defends against 2 strains of Leptospira: L. canicola and L. icterohaemorrhagiae
  • Protects against 2 types of adenovirus that cause hepatitis and respiratory disease in dogs
  • Provides disease coverage for commonly spread canine viruses, coronavirus, distemper, adenoviruses types 1 and 2, parainfluenza and parvovirus, in 1 formula
Indications
  • Approved for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper, adenovirus types 1 and 2, coronavirus, parainfluenza, parvovirus, and leptospiral disease due to L. canicola or L. icterohaemorrhagiae
  • Recommended for use in healthy dogs 6 weeks of age or older
Safety information
 Please see the product label
Administration and Dosage
  • Subcutaneous or intramuscular injection
  • Two 1 mL doses given 2 to 4 weeks apart
  • Repeat at 2 to 4 week intervals until 12 weeks of age
  • Annual revaccination with 1 dose is recommended
  • Available in a 25 x 1 mL dose